SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Crescent Capital BDC, Inc. (CCAP, FCRX) (CIK 0001633336) (CCAP) — Apr 30, 2018

Crescent Capital BDC, Inc. (CCAP, FCRX) (CIK 0001633336)
Date: April 30, 2018 · CIK: 0001633336 · Accession: 0001193125-18-143242

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 814-01117

Date
April 30, 2018
Author
/s/ Richard Horowitz
Form
CORRESP
Company
Crescent Capital BDC, Inc. (CCAP, FCRX) (CIK 0001633336)

Letter

Division of Investment Management Securities and Exchange Commission Washington, D.C. 20549-0504 Re: Crescent Capital BDC, Inc. Preliminary Proxy Statement on Schedule 14A File No. 814-01117

Dear Ms. Larkin:

We are writing in response to your comments provided telephonically on April 30, 2018 with respect to the preliminary proxy statement (the “Proxy Statement”) filed on Schedule 14A (“Schedule 14A”) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), on behalf of Crescent Capital BDC, Inc. (the “Corporation”) on March 29, 2018. The Corporation has considered your comments and has authorized us, on its behalf, to make the responses and changes discussed below to the Proxy Statement. These changes will be reflected in an upcoming Definitive Schedule 14A filing.

On behalf of the Corporation, set forth below are the Securities and Exchange Commission (“SEC”) staff’s comments along with our responses to or any supplemental explanations of such comments, as requested. Capitalized terms used herein but not defined shall have the same meaning as set forth in the Schedule 14A.

Proposal 3

Comment 1. Please confirm that the Advisor will not have any right to recoup any amount of waived fees in the future.

Response 1. The Corporation confirms that the Advisor shall not have any right to recoup any amount of the Base Management Fees or Incentive Fees that are waived under the Fee Waiver Agreement, including under the amended Fee Waiver Agreement if Proposal 3 and/or Proposal 4 are approved.

April 30, 2018

Page

Comment 2. Please add a footnote to the fee table in Proposal 3 that states that the amounts shown in the fee table are the fee rates assuming the Fee Waiver Agreement is in effect.

Response 2. The disclosure has been revised to add the following footnote:

The Base Management Fee and Incentive Fee rates shown in the table reflect the rates pursuant to the Fee Waiver Agreement. The Fee Waiver Agreement may be amended at any time with the approval of the Board and the Advisor, provided that pursuant to the Investment Advisory Agreement, the Base Management Fee may not exceed 1.50% of the Corporation’s gross assets (excluding cash) and the Income Fee rate may not exceed 15% prior to a Qualified IPO.

* * * *

Should you have any questions regarding this letter, please contact me at (212) 698-3525.

Sincerely,
/s/ Richard Horowitz

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 1095 Avenue of the Americas

 New York,
NY  10036-6797

 +1  212  698  3500  Main

+1  212  698  3599  Fax

 www.dechert.com

 RICHARD
HOROWITZ

richard.horowitz@dechert.com

 +1 212 698 3525  Direct

+1 212 698 0452  Fax

 April 30, 2018

 Lisa N.
Larkin

 Disclosure Review Office

 Division of Investment
Management

 Securities and Exchange Commission

100 F Street, N.E.

 Washington, D.C. 20549-0504

Re:
 Crescent Capital BDC, Inc.

Preliminary Proxy Statement on Schedule 14A

File No. 814-01117

Dear Ms. Larkin:

We are writing in response to your comments provided telephonically on April 30, 2018 with respect to the preliminary
proxy statement (the “Proxy Statement”) filed on Schedule 14A (“Schedule 14A”) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), on behalf of Crescent Capital BDC, Inc. (the
“Corporation”) on March 29, 2018. The Corporation has considered your comments and has authorized us, on its behalf, to make the responses and changes discussed below to the Proxy Statement. These changes will be reflected in an
upcoming Definitive Schedule 14A filing.

 On behalf of the Corporation, set forth below are the Securities and Exchange
Commission (“SEC”) staff’s comments along with our responses to or any supplemental explanations of such comments, as requested. Capitalized terms used herein but not defined shall have the same meaning as set forth in the Schedule
14A.

 Proposal 3

Comment 1.    Please confirm that the Advisor will not have any right to recoup any amount of waived
fees in the future.

 Response 1.        The
Corporation confirms that the Advisor shall not have any right to recoup any amount of the Base Management Fees or Incentive Fees that are waived under the Fee Waiver Agreement, including under the amended Fee Waiver Agreement if Proposal 3 and/or
Proposal 4 are approved.

April 30, 2018

  Page
 2

 Comment 2.    Please add a footnote to the fee table
in Proposal 3 that states that the amounts shown in the fee table are the fee rates assuming the Fee Waiver Agreement is in effect.

Response 2.    The disclosure has been revised to add the following footnote:

The Base Management Fee and Incentive Fee rates shown in the table reflect the rates pursuant to the Fee Waiver Agreement.
The Fee Waiver Agreement may be amended at any time with the approval of the Board and the Advisor, provided that pursuant to the Investment Advisory Agreement, the Base Management Fee may not exceed 1.50% of the Corporation’s gross assets
(excluding cash) and the Income Fee rate may not exceed 15% prior to a Qualified IPO.

*            *
 *            *

 Should you have any questions regarding this letter,
please contact me at (212) 698-3525.

 Sincerely,

/s/ Richard Horowitz

Richard Horowitz